Oridonin: Targeting programmed cell death pathways as an anti-tumour agent

Cell Proliferation

Volumn 45, Issue 6, 2012, Pages 499-507

  Liu, Z ^a   Ouyang, L ^b   Peng, H ^c   Zhang, W Z ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

^c Zhong Guan Cun Life Science Park   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; ORIDONIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL EXPANSION; CELL PROLIFERATION; DRUG MECHANISM; HUMAN; MITOCHONDRION; NONHUMAN; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AUTOPHAGY; DITERPENES, KAURANE; HUMANS; NEOPLASMS; RABDOSIA; SIGNAL TRANSDUCTION;

EID: 84868142361     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00849.x     Document Type: Article

References (75)

1. Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J et al. (2007) Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood 109, 3441-3450.
2. Ikezoe T, Chen SS, Tong XJ, Heber D, Taguchi H, Koeffler HP (2003) Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int. J. Oncol. 23, 1187-1193.
3. Zhou GB, Chen SJ, Wang ZY, Chen Z (2007) Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo. Cell Res. 17, 274-276.
4. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70.
5. Wen X, Lin ZQ, Liu B, Wei YQ (2012) Targeting caspase-mediated programmed cell death pathways for cancer therapy. Cell Prolif. 45, 217-224.
6. Liu JJ, Lin M, Yu JY, Liu B, Bao JK (2011) Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett. 300, 105-114.
7. Chen M, Wang J (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7, 313-319.
8. Tsuchihara K, Fujii S, Esumi H (2009) Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett. 278, 130-138.
9. Li ZY, Yang Y, Ming M, Liu B (2011) Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414, 5-8.
10. Li CY, Wang EQ, Cheng Y, Bao JK (2011) Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int. J. Biochem. Cell Biol. 43, 701-704.
11. Zhang X, Chen LX, Ouyang L, Cheng Y, Liu B (2012) Targeting autophagic pathways by plant natural compounds in cancer. Cell Prolif. 45, 466-476.
12. Fu LL, Wen X, Bao JK, Liu B (2012) MicroRNA-modulated autophagic signaling networks in cancer. Int. J. Biochem. Cell Biol. 44, 733-736.
13. Wang SY, Yu QJ, Zhang RD, Liu B (2011) Core signaling pathways of survival/death in autophagy-related cancer networks. Int. J. Biochem. Cell Biol. 43, 1263-1266.
14. Liu B, Cheng Y, Liu Q, Bao JK, Yang JM (2010) Autophagic pathways as new targets for cancer drug development. Acta Pharmacol. Sin. 31, 1154-1164.
15. Zhang CL, Wu LJ, Zuo HJ, Tashiro S, Onodera S, Ikejima T (2004) Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation. J. Pharmacol. Sci. 96, 155-163.
16. Zhang Y, Wu Y, Wu D, Tashiro S, Onodera S, Ikejima T (2009) NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway. Arch. Biochem. Biophys. 489, 25-33.
17. Li D, Cui Q, Chen SG, Wu LJ, Tashiro S, Onodera S et al. (2007) Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells. J. Pharmacol. Sci. 105, 22-33.
18. Cheng Y, Qiu F, Huang J, Tashiro S, Onodera S, Ikejima T (2008) Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death. Arch. Biochem. Biophys. 475, 148-155.
19. Zhu Y, Xie L, Chen G, Wang H, Zhang R (2007) Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice. Pharmazie 62, 439-444.
20. Node M, Sai M, Fuji K, Fujita E, Takeda S, Unemi N (1983) Antitumor activity of diterpenoids, trichorabdals A, B, and C, and the related compounds: synergism of two active sites. Chem. Pharm. Bull. (Tokyo) 31, 1433-1436.
21. Cheng Y, Qiu F, Ye YC, Tashiro S, Onodera S, Ikejima T (2009) Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells. Arch. Biochem. Biophys. 490, 70-75.
22. Kumar R, Herbert PE, Warrens AN (2005) An introduction to death receptors in apoptosis. Int. J. Surg. 3, 268-277.
23. Ikezoe T, Yang Y, Bandobashi K, Saito T, Takemoto S, Machida H et al. (2005) Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Mol. Cancer Ther. 4, 578-586.
24. Huang J, Wu L, Tashiro S, Onodera S, Ikejima T (2005) A comparison of the signal pathways between the TNF alpha- and oridonin-induced murine L929 fibrosarcoma cell death. Acta Med. Okayama 59, 261-270.
25. Xu Y, Xue Y, Wang Y, Feng D, Lin S, Xu L (2009) Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int. Immunopharmacol. 9, 360-365.
26. Liu YQ, Mu ZQ, You S, Tashiro S, Onodera S, Ikejima T (2006) Fas/FasL signaling allows extracellular-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells. Biol. Pharm. Bull. 29, 1873-1879.
27. Arismendi-Morillo G (2009) Electron microscopy morphology of the mitochondrial network in human cancer. Int. J. Biochem. Cell Biol. 41, 2062-2068.
28. Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112, 481-490.
29. Van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P (2002) The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9, 1031-1042.
30. Oberst A, Bender C, Green DR (2008) Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ. 15, 1139-1146.
31. Waterhouse NJ, Ricci JE, Green DR (2002) And all of a sudden it's over: mitochondrial outer-membrane permeabilization in apoptosis. Biochimie 84, 113-121.
32. Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693s-1700s.
33. Tsujimoto Y, Shimizu S (2000) Bcl-2 family: life-or-death switch. FEBS Lett. 466, 6-10.
34. Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004) Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929. Biol. Pharm. Bull. 27, 1527-1531.
35. Huang J, Wu L, Tashiro S, Onodera S, Ikejima T (2005) Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis. Biol. Pharm. Bull. 28, 2068-2074.
36. Liu J, Huang R, Lin D, Wu X, Peng J, Lin Q et al. (2005) Apoptotic effect of oridonin on NB4 cells and its mechanism. Leuk. Lymphoma 46, 593-597.
37. Zhang JF, Liu JJ, Liu PQ, Lin DJ, Li XD, Chen GH (2006) Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells. Hepatol. Res. 35, 104-110.
38. Liu JJ, Huang RW, Lin DJ, Wu XY, Lin Q, Peng J et al. (2005) Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro. Oncol. Rep. 13, 653-657.
39. Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004) Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome. J. Asian Nat. Prod. Res. 6, 127-138.
40. Liu JJ, Huang RW, Lin DJ, Wu XY, Peng J, Pan XL et al. (2005) Oridonin-induced apoptosis in leukemia K562 cells and its mechanism. Neoplasma 52, 225-230.
41. Zhen T, Wu CF, Liu P, Wu HY, Zhou GB, Lu Y et al. (2012) Targeting of AML1-ETO in t (8;21) leukemia by oridonin generates a tumor suppressor-like protein. Sci. Transl. Med. 4, 127-138.
42. Dan I, Watanabe NM, Kusumi A (2001) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11, 220-230.
43. Whitmarsh AJ, Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. (Berl) 74, 589-607.
44. Krens SF, Spaink HP, Snaar-Jagalska BE (2006) Functions of the MAPK family in vertebrate-development. FEBS Lett. 580, 4984-4990.
45. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344.
46. Jin S, Shen JN, Wang J, Huang G, Zhou JG (2007) Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biol. Ther. 6, 261-268.
47. Li D, Wu LJ, Tashiro S, Onodera S, Ikejima T (2007) Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway. J. Pharmacol. Sci. 103, 56-66.
48. Huang J, Wu L, Tashiro S, Onodera S, Ikejima T (2008) Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J. Pharmacol. Sci. 107, 370-379.
49. Liu YQ, You S, Tashiro S, Onodera S, Ikejima T (2005) Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells. J. Pharmacol. Sci. 98, 361-371.
50. Liu YQ, You S, Tashiro S, Onodera S, Ikejima T (2006) Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells. Int. Immunopharmacol. 6, 260-268.
51. Foukas LC, Katsoulas HL, Paraskevopoulou N, Metheniti A, Lambropoulou M, Marmaras VJ (1998) Phagocytosis of Escherichia coli by insect hemocytes requires both activation of the Ras/mitogen-activated protein kinase signal transduction pathway for attachment and beta3 integrin for internalization. J. Biol. Chem. 273, 14813-14818.
52. Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
53. Li D, Wu LJ, Tashiro S, Onodera S, Ikejima T (2007) Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells. Biol. Pharm. Bull. 30, 254-260.
54. Wang HJ, Li D, Yang FY, Tashiro S, Onodera S, Ikejima T (2008) Oridonin induces human melanoma A375-S2 cell death partially through inhibiting insulin-like growth factor 1 receptor signaling. J. Asian Nat. Prod. Res. 10, 787-798.
55. Huang J, Wu L, Tashiro S, Onodera S, Ikejima T (2006) Fibroblast growth factor-2 suppresses oridonin-induced L929 apoptosis through extracellular signal-regulated kinase-dependent and phosphatidylinositol 3-kinase-independent pathway. J. Pharmacol. Sci. 102, 305-313.
56. Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 9, 550-562.
57. Liu YQ, You S, Zhang CL, Tashiro S, Onodera S, Ikejima T (2005) Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells. Biol. Pharm. Bull. 28, 461-467.
58. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
59. Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90.
60. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
61. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
62. Hu HZ, Yang YB, Xu XD, Shen HW, Shu YM, Ren Z et al. (2007) Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta Pharmacol. Sin. 28, 1819-1826.
63. Gao FH, Hu XH, Li W, Liu H, Zhang YJ, Guo ZY et al. (2010) Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc. BMC Cancer 10, 610.
64. Huang HL, Weng HY, Wang LQ, Yu CH, Huang QJ, Zhao PP et al. (2012) Triggering Fbw7-mediated proteasomal degradation of c-Myc by Oridonin induces cell growth inhibition and apoptosis. Mol. Cancer Ther. 11, 1155-1165.
65. Cui Q, Tashiro S, Onodera S, Minami M, Ikejima T (2007) Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation. J. Pharmacol. Sci. 105, 317-325.
66. Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348.
67. Huang J, Klionsky DJ (2007) Autophagy and human disease. Cell Cycle 6, 1837-1849.
68. Cui Q, Tashiro S, Onodera S, Ikejima T (2006) Augmentation of oridonin-induced apoptosis observed with reduced autophagy. J. Pharmacol. Sci. 101, 230-239.
69. Zhang Y, Wu Y, Tashiro S, Onodera S, Ikejima T (2009) Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: a protective mechanism against apoptosis. Biochem. Biophys. Res. Commun. 378, 273-278.
70. Cui Q, Tashiro S, Onodera S, Minami M, Ikejima T (2007) Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol. Pharm. Bull. 30, 859-864.
71. Cheng Y, Qiu F, Ye YC, Guo ZM, Tashiro S, Onodera S et al. (2009) Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J. 276, 1291-1306.
72. Cheng Y, Qiu F, Ikejima T (2009) Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells. Autophagy 5, 430-431.
73. Zhang YH, Wu YL, Tashiro S, Onodera S, Ikejima T (2011) Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacol. Sin. 32, 1266-1275.
74. Zeng R, Chen Y, Zhao S, Cui GH (2012) Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1. Acta Pharmacol. Sin. 33, 91-100.
75. Zang L, Xu Q, Ye Y, Li X, Liu Y, Tashiro S et al. (2012) Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells. Arch. Biochem. Biophys. 518, 31-41.